Initial Public Offering (Details Narrative) - $ / shares |
6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Mar. 27, 2026 |
Dec. 16, 2025 |
Oct. 01, 2025 |
Dec. 20, 2024 |
Jan. 09, 2023 |
Jan. 04, 2023 |
Jun. 30, 2026 |
|
| Subsidiary, Sale of Stock [Line Items] | |||||||
| Issuance of share to sponsor, shares | 69 | 917,814 | 3,403,976 | 6,204 | |||
| Sale of stock, price per share | $ 12.99 | ||||||
| Units description | the Company held an extraordinary general meeting (the “Fifth Meeting”), solely with respect to voting on (i) the proposal to extend the date by which the Company must complete its initial business combination from April 4, 2026 to December 4, 2026, with all eight (8) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend the Termination Date up to eight (8) times, with each extension comprised of one month each from the Termination Date, or extended date, as applicable, to December 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date, or extended date, and depositing into the trust account $15,000 for each monthly extension until December 4, 2026. | ||||||
| IPO [Member] | |||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||
| Issuance of share to sponsor, shares | 6,900,000 | ||||||
| Issuance of share to sponsor, shares | 6,000,000 | ||||||
| Sale of stock, price per share | $ 10.00 | ||||||
| Warrant exercise price | $ 11.50 | ||||||
| Units description | Each Right entitles the holder thereof to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the initial Business Combination. | ||||||
| Over-Allotment Option [Member] | |||||||
| Subsidiary, Sale of Stock [Line Items] | |||||||
| Issuance of share to sponsor, shares | 900,000 | ||||||
| Sale of stock, price per share | $ 10.00 |